35 studies found for:    "Encephalitis, Tick-Borne"
Show Display Options
Rank Status Study
21 Completed FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years
Condition: Encephalitis, Tick-borne
Intervention: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
22 Completed FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years
Condition: Encephalitis, Tick-borne
Intervention: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
23 Completed Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR
Condition: Encephalitis, Tick-borne
Intervention: Biological: Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
24 Recruiting New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly
Condition: Tick-borne Encephalitis
Intervention: Biological: FSME-immune
25 Completed Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination
Condition: Tick-borne Encephalitis
Intervention: Biological: TBE vaccination and influenza vaccination
26 Unknown  Evaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Protective Traveler Schemes With Inactivated TBE Whole Virus Vaccine
Condition: Tick Borne Encephalitis
Intervention: Biological: FSME vaccination (FSME-Immun)
27 Recruiting Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients
Condition: Tick Borne Encephalitis
Intervention: Biological: TBE virus vaccine
28 Completed TBE Seropersistence up to 10 Years After First Booster in Adults
Condition: Tick-borne Encephalitis (TBE)
Intervention: Biological: FSME-IMMUN 0.5 ml
29 Unknown  Postencephalitic Symptoms After Tick Borne Encephalitis
Condition: Central European Encephalitis
Intervention:
30 Completed Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years
Condition: Tick-borne Encephalitis
Intervention: Biological: FSME-IMMUN NEW 0.25 ml
31 Completed Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.
Condition: Tick-borne Encephalitis
Intervention: Biological: Tick-borne encephalitis vaccine
32 Completed Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years
Condition: Tick-borne Encephalitis
Intervention: Biological: FSME-IMMUN 0.5ml
33 Completed Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.
Condition: Tick-borne Encephalitis
Intervention: Biological: Tick-borne Encephalitis Vaccine
34 Completed Influence of Persistent CMV-infection on Immune Senescence
Condition: Immune Senescence
Intervention: Biological: Vaccination against TBEV (FSME Immun CC)
35 Recruiting Aseptic Meningoencephalitis in Slovenia
Condition: Aseptic Meningitis
Interventions: Drug: symptomatic therapy;   Drug: Ceftriaxone or Doxycycline;   Other: questionnaire;   Drug: Acyclovir

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page   
Indicates status has not been verified in more than two years